Erasca, Inc. (ERAS)
14.41
+1.14
(+8.59%)
USD |
NASDAQ |
Nov 06, 16:00
14.52
+0.11
(+0.76%)
After-Hours: 20:00
Erasca Free Cash Flow : -98.08M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -98.08M |
| March 31, 2026 | -91.36M |
| December 31, 2025 | -95.58M |
| September 30, 2025 | -98.43M |
| June 30, 2025 | -99.19M |
| March 31, 2025 | -107.82M |
| December 31, 2024 | -109.48M |
| September 30, 2024 | -109.78M |
| June 30, 2024 | -111.72M |
| March 31, 2024 | -108.72M |
| December 31, 2023 | -102.99M |
| September 30, 2023 | -105.36M |
| Date | Value |
|---|---|
| June 30, 2023 | -106.74M |
| March 31, 2023 | -112.24M |
| December 31, 2022 | -117.82M |
| September 30, 2022 | -118.89M |
| June 30, 2022 | -121.05M |
| March 31, 2022 | -108.16M |
| December 31, 2021 | -90.80M |
| September 30, 2021 | -75.61M |
| June 30, 2021 | -55.34M |
| March 31, 2021 | -43.25M |
| December 31, 2020 | -33.63M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Twist Bioscience Corp. | -93.22M |
| Immunome, Inc. | -219.09M |
| Oncolytics Biotech, Inc. | -26.53M |
| Sangamo Therapeutics, Inc. | -90.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.27M |
| Cash from Investing (Quarterly) | 19.49M |
| Cash from Financing (Quarterly) | 3.064M |
| Free Cash Flow Per Share (Quarterly) | -0.0876 |
| Free Cash Flow to Equity (Quarterly) | -26.04M |
| Free Cash Flow to Firm (Quarterly) | -27.28M |
| Free Cash Flow Yield | -2.30% |